Hong Kong stock anomaly | HB Medicine-B (02142.HK) rises by over 5% again, intending to offer a discount of approximately 9.45% for the rights issue. The net proceeds raised will be used for expanding and developing innovative drug assets.
According to the Securities Times app, Haploid Medicine-B (02142.HK) has risen by over 5% again, as of the time of writing, it has risen by 5.2% to HK$13.36, with a turnover of HK$85.495 million.
Latest
